MENU
+Compare
PEN
Stock ticker: NYSE
AS OF
Jan 14, 04:59 PM (EDT)
Price
$313.30
Change
+$12.33 (+4.10%)
Capitalization
11.79B

PEN Penumbra Forecast, Technical & Fundamental Analysis

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots... Show more

PEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PEN with price predictions
Jan 13, 2026

Momentum Indicator for PEN turns negative, indicating new downward trend

PEN saw its Momentum Indicator move below the 0 level on January 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PEN moved out of overbought territory on December 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where PEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PEN turned negative on December 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The 50-day moving average for PEN moved above the 200-day moving average on December 09, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

PEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 234 cases where PEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.673) is normal, around the industry mean (62.991). P/E Ratio (71.831) is within average values for comparable stocks, (38.209). Projected Growth (PEG Ratio) (0.695) is also within normal values, averaging (1.662). PEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (8.953) is also within normal values, averaging (39.712).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PEN is expected to report earnings to rise 13.40% to $1.10 per share on February 24

Penumbra PEN Stock Earnings Reports
Q4'25
Est.
$1.10
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.07
The last earnings report on November 05 showed earnings per share of 97 cents, beating the estimate of 92 cents. With 290.50K shares outstanding, the current market capitalization sits at 11.79B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
4200
Web
https://www.penumbrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMIG29.620.02
+0.05%
Bahl & Gaynor Sm/Md Cp Inc Gr ETF
IBGK23.72-0.04
-0.17%
iShares iBonds Dec 2054 Term Trsy ETF
TWOX28.47-0.09
-0.33%
iShares Large Cp Accelerated Outcome ETF
WDIV76.21-0.54
-0.70%
SPDR® S&P Global Dividend ETF
EMM35.21-0.34
-0.95%
Global X Emerging Markets ex-China ETF

PEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with PODD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then PODD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-5.79%
PODD - PEN
43%
Loosely correlated
-0.14%
ISRG - PEN
42%
Loosely correlated
-1.91%
BSX - PEN
41%
Loosely correlated
-1.65%
SYK - PEN
39%
Loosely correlated
-1.54%
MASI - PEN
38%
Loosely correlated
-1.82%
More

Groups containing PEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-5.79%
Medical/Nursing Services
industry (220 stocks)
14%
Poorly correlated
-0.32%
Health Services
industry (412 stocks)
5%
Poorly correlated
-0.23%